News | Breast Imaging | August 02, 2019

Volpara to Distribute Screenpoint Medical's Transpara AI Solution

Volpara will sell artificial intelligence-powered breast cancer detection solution in the U.S., Australia, New Zealand and parts of Asia

Volpara to Distribute Screenpoint Medical's Transpara AI Solution

August 2, 2019 — Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara products to breast imaging clinics in the United States, Australia, New Zealand and parts of Asia. Transpara is designed to assist radiologists with the reading of mammograms and is one of the first next-generation artificial intelligence (AI) applications for detecting breast cancer in screening mammograms to gain 510(k) clearance from the U.S. Food & Drug Administration (FDA).

FDA clearance was supported by the results of a multi-reader, multi-case reader study published in February 2019 in Radiology, which demonstrated that radiologists using Transpara significantly improved detection accuracy without increasing reading times.1 Radiologists' performance consistently improved independent of their level of experience. In the JNCI publication that followed in March, it was reported that when compared to 101 radiologists, the stand-alone performance (sensitivity and specificity) of Transpara was as accurate.2 This suggests that the system gives an objective second opinion similar to that of a second radiologist. 

Transpara gained European regulatory approval (CE) for use with multi-vendor mammography (2018) and digital breast tomosynthesis (DBT) images (2019), and is already installed at breast imaging centers in Europe.

Both companies showcased their complete suite of breast imaging analytics tools at the Association for Medical Imaging Management (AHRA) 2019 Annual Meeting, July 21-24 in Denver.

For more information: www.volparasolutions.com, www.screenpoint-medical.com

Reference

1. Rodriguez-Ruiz A., Krupinski E., Mordang J., et al. Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System. Radiology, published online Nov. 20, 2018. https://doi.org/10.1148/radiol.2018181371

2. Rodriguez-Ruiz A., Lang K., Gubern-Merida A., et al. Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists. Journal of the National Cancer Institute, March 5, 2019. https://doi.org/10.1093/jnci/djy222

Related Content

 Riverain Technologies will showcase its artificial intelligence solutions and enhancements at the now-virtual 2020 Radiological Society of North America Annual Meeting (RSNA).
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Riverain Technologies will showcase its...
Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
News | Radiology Imaging | December 02, 2020
December 2, 2020 — Samsung Electronics Co., Ltd.
Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius 3D Mammography exam
News | Breast Imaging | December 02, 2020
December 2, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s hea
 Philips highlighted its expanding enterprise imaging informatics portfolio that is enabling healthcare providers to advance digital health transformation at RSNA 2020.
News | Enterprise Imaging | December 02, 2020
December 2, 2020 — Philips highlighted its expanding...
Glassbeam Clinsights can help imaging departments capture service data to enhance operational efficiencies
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Hospitals and institutions face a significant challenge each year when it comes to the financial i
Lunit’s algorithm showed the best performance compared to other commercialized AI algorithms, ultimately reducing the workload of radiologists to classify mammography screenings
News | Artificial Intelligence | December 02, 2020
December 2, 2020 — Recent studies have shown that Lunit’s AI solution is as accurate as average radiologists when it
A cut-away view of the two cabins that compose the "CT-in-a-box" solution from GE to rapidly deploy CT scanners at hospitals amid a COVID surge. The CT room is completely separate from the control room to aid in sanitation and keeping technologists away from COVID patients.

A cut-away view of the two cabins that compose the "CT-in-a-box" solution from GE to rapidly deploy CT scanners at hospitals amid a COVID surge. The CT room is completely separate from the control room to aid in sanitation and keeping technologists away from COVID patients. Image by GE Healthcare.

Feature | Coronavirus (COVID-19) | December 01, 2020
December 1, 2020 — As hospitals see an influx of...
The GE Healthcare Allia IGS 71 angiography system. #RSNA #RSNA20 #RSNA2020

The GE Healthcare Allia IGS 71 angiography system.

News | Angiography | December 01, 2020
December 3, 2020 — GE Healthcare is introducing a new, smaller and lighter weight robotic driven ...
Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging. #RSNA20 #RSNA2020

Medical imaging artificial intelligence (AI) vendor Avicenna.AI announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.
 

News | Stroke | December 01, 2020
December 1, 2020 – Medical imaging ...